Back to search
FDAFDA · Food and drugs·Recall number Z-0256-2013

Sysmex XE-2100C Automated Hematology System; an automated differential cell counter; Sysmex Corporation, Kobe, Japan; Sysmex America, One Nelson C. White Parkway, Mundelein, IL 60060; catalog #053-2311-4 The Sysmex XE-2100C is an automated hematology analyzer for in vitro diagnostic use in screening patient populations found in clinical laboratories.

Published November 14, 2012 · Recall initiated: June 1, 2012

Summary

FDA records medical device Class II recall Z-0256-2013, published November 14, 2012 and initiated June 1, 2012. Recalling firm: Sysmex America, Inc.; Status: Terminated; Reported quantity: 69 units; Lot: catalog ##053-2311-4, all serial numbers. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

There is a variation of reticulocyte counts between XE Series (XE-2100, XE-5000) and XT-Series (XT-2000i, XT-4000i) hematology analyzers that may result in a retic counts that are an average of 21% lower on the XE-Series because of a low bias.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sysmex America, Inc.
Distributor
Nationwide distribution: USA including Puerto Rico.
Lot
catalog ##053-2311-4, all serial numbers
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Sysmex XE-2100C Automated Hematology System; an automated differential cell counter; Sysmex Corporation, Kobe, Japan; Sysmex America, One Nelson C. White Parkway, Mundelein, IL 60060; catalog #053-2311-4 The Sysmex XE-2100C is an automated hematology analyzer for in vitro diagnostic use in screening patient populations found in clinical laboratories. recalled?

Yes. FDA published recall Z-0256-2013 on November 14, 2012. Reported hazard: There is a variation of reticulocyte counts between XE Series (XE-2100, XE-5000) and XT-Series (XT-2000i, XT-4000i) hematology analyzers that may result in a retic counts that are an average of 21% lower on the XE-Series because of a low bias.

What should I do if I have this product?

Voluntary: Firm initiated · Letter